+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Alopecia Market Size, Share & Trends Analysis Report by Disease Type (Alopecia Areata, Cicatricial, Traction, androgenetic Alopecia), by Treatment, by Gender, by Sales Channel, by End-use, by Region, and Segment Forecasts, 2021 - 2028

  • ID: 4764586
  • Report
  • July 2021
  • Region: Global
  • 120 pages
  • Grand View Research

FEATURED COMPANIES

  • Capillus
  • Cirrus Hair Centers
  • Follica, Inc.
  • Lexington Intl., LLC.
  • Merck & Co., Inc
  • Theradome

The global alopecia market size is expected to reach USD 14.2 billion by 2028. The market is expected to expand at a CAGR of 8.1% from 2021 to 2028. The strong presence of pipeline products and increasing approval for laser-based therapy to treat hair loss conditions are major factors anticipated to drive growth. Moreover, rising awareness among patients about alopecia and its treatments, increasing government initiatives, supportive regulations & laws, and improvements in healthcare infrastructure are factors expected to propel market growth over the forecast period.

Technological advancements in alopecia treatment are among the key drivers of this market. There are two FDA-approved therapeutics for alopecia-Rogaine and Propecia. There has been an increase in market penetration of generics after patent expiries of both drugs. However, the launch of several promising pipeline candidates over the forecast years such as Xeljanz (tofacitinib), Breezula (clascoterone), Jakafi (ruxolitinib), SM04554, and Lumigan (Bimatoprost) is expected to substantially drive the growth of the market in the near future.

The introduction of low-level laser therapy that helps stimulate hair growth is expected to increase the treatment rate among patients facing hair loss. In addition, the launch of laser caps, helmets, combs, and bands is also anticipated to boost the market growth. For instance, Capillus Laser Cap, iGrow Laser Helmet, iRestore Hair Growth System, and Hairmax Laser devices are some of the technologically advanced products available in the market.

Moreover, the increasing prevalence of diseases such as cancer, Polycystic Ovary Syndrome, and rheumatoid arthritis which are associated with hair loss is also expected to boost the treatment rate of hair loss in the near future. For instance, as per the U.S. Department of Health and Human Services, nearly 5 million women in the U.S. are affected by PCOS. Furthermore, according to the GBD database, the prevalence of PCOS in European countries, such as France, increased from 872,351 to 882,322 in 2018 & 2019, respectively, and in the U.K., the prevalence was found to be 1,134,082 to 1,142,498.

Market players are increasingly forming partnerships and licensing agreements to enhance their product capabilities and promote the outreach of their products. For instance, the iGrow laser system has a partnership with China Central Pharmaceuticals in China. China Central Pharmaceuticals holds exclusive distribution rights over Aspira in the country. Moreover, Capillus, LLC has collaborated with Svenson, a hair loss treatment clinic to expand the distribution of laser therapy caps in Europe and Asia Pacific region. The partnership with local players and service providers is expected to increase the adoption of innovative therapy for hair loss treatment.

Additionally, companies are actively participating in scientific conferences and conducting awareness campaigns for creating brand awareness. For instance, in February 2021, Hairmax welcomed Mary Brunetti as the brand ambassador to increase brand awareness about dealing with COVID-19-induced hair loss, as well as hereditary loss. Moreover, it plans to leverage the popularity of the brand ambassador to showcase its target market as to how its products can help regrow and revitalize their hair.

However, reimbursement remains one of the major challenges in this market. Since most of the treatment modalities are considered as not medically essential and are categorized as cosmetic procedures, the treatment for hair loss is generally not covered under insurance plans. Out-of-pocket expenses for alopecia treatment usually include prescription drug copays, frequent doctor visits, and co-insurance for procedures. Moreover, increasing adoption of substitutes, such as traditional medicines-Ayurvedic, Chinese, and herbal medications may hamper the growth of the market. Based on results from the GlaxoSmithKline plc sponsored survey, around 22.7% of the patients took Chinese medications for treating male androgenetic alopecia in South Korea followed by Taiwan with 22.0% patients.

Alopecia Market Report Highlights

  • In 2020, the alopecia areata segment accounted for the largest revenue share and is anticipated to maintain its dominance over the forecast period
  • Key late-stage pipeline candidates in the treatment of hair loss include: Xeljanz (tofacitinib), Breezula (clascoterone), and SM04554 are expected to fuel the growth in the coming years
  • Alopecia universalis is anticipated to witness the fastest growth during the forecast period owing to the potential pipeline products, such as BNZ-1 (Bioniz Therapeutics), and stem cell educator therapy with minoxidil (Tianhe Stem Cell Biotechnologies, Inc.)
  • North America was the largest market in 2020 mainly due to a high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improved healthcare infrastructure
  • Europe held the second-largest market share in 2020 given the high prevalence of AGA i.e., 80% and 50% in both the men and women of the region, respectively
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Capillus
  • Cirrus Hair Centers
  • Follica, Inc.
  • Lexington Intl., LLC.
  • Merck & Co., Inc
  • Theradome

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Outlook

Chapter 3 Alopecia Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing global prevalence of alopecia
3.3.1.2 Increasing global healthcare expenditure
3.3.1.3 Increasing prevalence of chronic diseases
3.3.1.3.1 PCOS
3.3.1.3.2 Cancer
3.3.1.3.3 Rheumatoid Arthritis
3.3.1.4 Technological advancements in alopecia treatment
3.3.2 Market restraint analysis
3.3.2.1 Lack of reimbursement policies for alopecia treatment
3.3.2.2 Increasing adoption of substitutes
3.4 Alopecia: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Pipeline Analysis

Chapter 4 Alopecia Market: Segment Analysis, By Disease Type, 2017 - 2028 (USD Million)
4.1 Alopecia Market: Disease Type Movement Analysis
4.2 Market Size & Forecasts and Trend Analyses, 2017 to 2028
4.2.1 Alopecia Areata
4.2.1.1 Alopecia areata market, 2017 - 2028 (USD Million)
4.2.1.2 Male alopecia areata market, 2017 - 2028 (USD Million)
4.2.1.3 Female alopecia areata market, 2017 - 2028 (USD Million)
4.2.2 Cicatricial Alopecia
4.2.2.1 Cicatricial alopecia market, 2017 - 2028 (USD Million)
4.2.2.2 Male cicatricial alopecia market, 2017 - 2028 (USD Million)
4.2.2.3 Female cicatricial alopecia market, 2017 - 2028 (USD Million)
4.2.3 Traction Alopecia
4.2.3.1 Traction alopecia market, 2017 - 2028 (USD Million)
4.2.3.2 Male traction alopecia market, 2017 - 2028 (USD Million)
4.2.3.3 Female traction alopecia market, 2017 - 2028 (USD Million)
4.2.4 Alopecia Totalis
4.2.4.1 Alopecia totalis market, 2017 - 2028 (USD Million)
4.2.4.2 Male alopecia totalis market, 2017 - 2028 (USD Million)
4.2.4.3 Female alopecia totalis market, 2017 - 2028 (USD Million)
4.2.5 Alopecia Universalis
4.2.5.1 Alopecia universalis market, 2017 - 2028 (USD Million)
4.2.5.2 Male alopecia universalis market, 2017 - 2028 (USD Million)
4.2.5.3 Female alopecia universalis market, 2017 - 2028 (USD Million)
4.2.6 androgenetic Alopecia
4.2.6.1 androgenetic alopecia market, 2017 - 2028 (USD Million)
4.2.6.2 Male androgenetic alopecia market, 2017 - 2028 (USD Million)
4.2.6.3 Female androgenetic alopecia market, 2017 - 2028 (USD Million)
4.2.7 Others
4.2.7.1 Other alopecia market, 2017 - 2028 (USD Million)
4.2.7.2 Male other alopecia market, 2017 - 2028 (USD Million)
4.2.7.3 Female other alopecia market, 2017 - 2028 (USD Million)

Chapter 5 Alopecia Market: Segment Analysis, By Treatment, 2017 - 2028 (USD Million)
5.1 Alopecia Market: Treatment Movement Analysis
5.2 Market Size & Forecasts and Trend Analyses, 2017 to 2028
5.2.1 Pharmaceuticals
5.2.1.1 Pharmaceuticals market, 2017 - 2028 (USD Million)
5.2.2 Devices
5.2.2.1 Devices market, 2017 - 2028 (USD Million)
5.2.2.1.1 LaseMD + LaseMD Ultra market, 2017 - 2028 (USD Million)
5.2.2.1.2 iRestore Essential + Professional market, 2017 - 2028 (USD Million)
5.2.2.1.3 HairMax Laser cap market, 2017 - 2028 (USD Million)
5.2.2.1.4 HairMax Laser band market, 2017 - 2028 (USD Million)
5.2.2.1.5 HairMax Laser Comb market, 2017 - 2028 (USD Million)
5.2.2.1.6 Capillus Laser Cap market, 2017 - 2028 (USD Million)
5.2.2.1.7 iGrow Laser Helmet market, 2017 - 2028 (USD Million)
5.2.2.1.8 Revian Red Helmet market, 2017 - 2028 (USD Million)
5.2.2.1.9 Theradome Helmet market, 2017 - 2028 (USD Million)

Chapter 6 Alopecia Market: Segment Analysis, By Gender, 2017 - 2028 (USD Million)
6.1 Alopecia Market: Gender Movement Analysis
6.2 Market Size & Forecasts and Trend Analyses, 2017 to 2028
6.2.1 Male
6.2.1.1 Male market, 2017 - 2028 (USD Million)
6.2.2 Female
6.2.2.1 Female market, 2017 - 2028 (USD Million)

Chapter 7 Alopecia Market: Segment Analysis, By Sales Channel, 2017 - 2028 (USD Million)
7.1 Alopecia Market: Sales Channel Movement Analysis
7.2 Market Size & Forecasts and Trend Analyses, 2017 to 2028
7.2.1 Prescriptions
7.2.1.1 Prescriptions market, 2017 - 2028 (USD Million)
7.2.2 OTC
7.2.2.1 OTC market, 2017 - 2028 (USD Million)

Chapter 8 Alopecia Market: Segment Analysis, By End Use, 2017 - 2028 (USD Million)
8.1 Alopecia Market: End Use Movement Analysis
8.2 Market Size & Forecasts and Trend Analyses, 2017 to 2028
8.2.1 Homecare Settings
8.2.1.1 Homecare settings market, 2017 - 2028 (USD Million)
8.2.2 Dermatology Clinics
8.2.2.1 Dermatology clinics market, 2017 - 2028 (USD Million)

Chapter 9 Alopecia Market: Segment Analysis, By Region, 2017 - 2028 (USD Million)
9.1 Alopecia Market: Regional Movement Analysis
9.2 Regional Market Share Analysis, 2020 & 2028
9.3 Regional Market Snapshot
9.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2017 to 2028
9.4.1 North America
9.4.1.1 North America market estimates and forecast, 2017 - 2028 (USD Million)
9.4.1.2 U.S.
9.4.1.2.1 U.S. alopecia market, 2017 - 2028 (USD Million)
9.4.1.3 Canada
9.4.1.3.1 Canada alopecia market, 2017 - 2028 (USD Million)
9.4.2 Europe
9.4.2.1 Europe alopecia market, 2017 - 2028 (USD Million)
9.4.2.2 U.K.
9.4.2.2.1 U.K. alopecia market, 2017 - 2028 (USD Million)
9.4.2.3 Germany
9.4.2.3.1 Germany alopecia market, 2017 - 2028 (USD Million)
9.4.2.4 Spain
9.4.2.4.1 Spain alopecia market, 2017 - 2028 (USD Million)
9.4.2.5 France
9.4.2.5.1 France alopecia market, 2017 - 2028 (USD Million)
9.4.2.6 Italy
9.4.2.6.1 Italy alopecia market, 2017 - 2028 (USD Million)
9.4.3 Asia Pacific
9.4.3.1 Asia Pacific alopecia market, 2017 - 2028 (USD Million)
9.4.3.2 Japan
9.4.3.2.1 Japan alopecia market, 2017 - 2028 (USD Million)
9.4.3.3 China
9.4.3.3.1 China alopecia market, 2017 - 2028 (USD Million)
9.4.3.4 India
9.4.3.4.1 India alopecia market, 2017 - 2028 (USD Million)
9.4.3.5 South Korea
9.4.3.5.1 South Korea alopecia market, 2017 - 2028 (USD Million)
9.4.3.6 Australia
9.4.3.6.1 Australia alopecia market, 2017 - 2028 (USD Million)
9.4.4 Latin America
9.4.4.1 Latin America alopecia market, 2017 - 2028 (USD Million)
9.4.4.2 Brazil
9.4.4.2.1 Brazil alopecia market, 2017 - 2028 (USD Million)
9.4.4.3 Mexico
9.4.4.3.1 Mexico alopecia market, 2017 - 2028 (USD Million)
9.4.5 MEA
9.4.5.1 MEA alopecia market, 2017 - 2028 (USD Million)
9.4.5.2 South Africa
9.4.5.2.1 South Africa alopecia market, 2017 - 2028 (USD Million)
9.4.5.3 Saudi Arabia
9.4.5.3.1 Saudi Arabia alopecia market, 2017 - 2028 (USD Million)

Chapter 10 Alopecia Market: Competitive Analysis
10.1 Recent Developments and Impact Analysis, by Key Market Participants
10.1.1 Major Deals and Strategic Alliances Analysis
10.1.1.1 New Product Launches
10.1.1.2 Partnerships and Licensing Agreements
10.1.1.3 Conferences and Campaigns
10.2 Company Categorization
10.2.1 Innovators
10.2.2 Market Leaders
10.2.3 Heat map analysis
10.3 Vendor Landscape
10.3.1 List of key distributors and channel partners
10.3.2 Key customers
10.4 Public Companies
10.4.1 Competitive dashboard analysis
10.4.1.1 Market Differentiators
10.5 Private Companies
10.5.1 List of key emerging companies
10.6 Company Profiles (Pharmaceutical)
10.6.1 Cipla, Inc.
10.6.1.1 Company overview
10.6.1.2 Financial performance
10.6.1.3 Product benchmarking
10.6.1.4 Strategic initiatives
10.6.2 Sun Pharmaceuticals Industries Ltd.
10.6.2.1 Company overview
10.6.2.2 Financial performance
10.6.2.3 Product benchmarking
10.6.2.4 Strategic initiatives
10.6.3 Johnson & Johnson Services, Inc.
10.6.3.1 Company overview
10.6.3.2 Financial performance
10.6.3.3 Product benchmarking
10.6.3.4 Strategic initiatives
10.6.4 Merck & Co., Inc
10.6.4.1 Company overview
10.6.4.2 Financial performance
10.6.4.3 Product benchmarking
10.6.4.4 Strategic initiatives
10.6.5 Lexington Intl., LLC
10.6.5.1 Company overview
10.6.5.2 Financial performance
10.6.5.3 Product benchmarking
10.6.5.4 Strategic initiatives
10.6.6 Cirrus Hair Centers
10.6.6.1 Company overview
10.6.6.2 Financial performance
10.6.6.3 Product benchmarking
10.6.6.4 Strategic initiatives
10.6.7 Vita-Cos-Med Klett-Loch GmbH
10.6.7.1 Company overview
10.6.7.2 Financial performance
10.6.7.3 Product benchmarking
10.6.7.4 Strategic initiatives
10.6.8 Transitions Hair
10.6.8.1 Company overview
10.6.8.2 Financial performance
10.6.8.3 Product benchmarking
10.6.8.4 Strategic initiatives
10.6.9 Follica, Inc.
10.6.9.1 Company overview
10.6.9.2 Financial performance
10.6.9.3 Product benchmarking
10.6.9.4 Strategic initiatives
10.6.10 Capillus
10.6.10.1 Company overview
10.6.10.2 Financial performance
10.6.10.3 Product benchmarking
10.6.10.4 Strategic initiatives
10.7 Company Profiles (Devices)
10.7.1 Lexington Intl., LLC.
10.7.1.1 Company overview
10.7.1.2 Product benchmarking
10.7.1.3 Strategic initiatives
10.7.2 Freedom Laser Therapy (iRestore ID-520 helmet)
10.7.2.1 Company overview
10.7.2.2 Product benchmarking
10.7.2.3 Strategic initiatives
10.7.3 Curallux, LLC.
10.7.3.1 Company overview
10.7.3.2 Product benchmarking
10.7.3.3 Strategic initiatives
10.7.4 Apira science Inc. (iGROW Laser)
10.7.4.1 Company overview
10.7.4.2 Product benchmarking
10.7.4.3 Strategic initiatives
10.7.5 Revian Inc.
10.7.5.1 Company overview
10.7.5.2 Product benchmarking
10.7.5.3 Strategic initiatives
10.7.6 Theradome
10.7.6.1 Company overview
10.7.6.2 Product benchmarking
10.7.6.3 Strategic initiatives
10.7.7 lutronic
10.7.7.1 Company overview
10.7.7.2 Product benchmarking

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Healthcare reimbursement in last four years (% of GDP)
Table 4 List of late-stage clinical trials
Table 5 List of parameters
Table 6 Leading market players anticipated to witness the highest growth
Table 7 List of key distributors
Table 8 North America Alopecia Market, By Country, 2017 - 2028 (USD Million)
Table 9 North America Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 10 North America Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 11 North America Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 12 North America Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 13 North America Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 14 U.S. Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 15 U.S. Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 16 U.S. Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 17 U.S. Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 18 U.S. Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 19 Canada Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 20 Canada Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 21 Canada Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 22 Canada Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 23 Canada Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 24 Europe Alopecia Market, By Country, 2017 - 2028 (USD Million)
Table 25 Europe Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 26 Europe Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 27 Europe Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 28 Europe Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 29 Europe Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 30 U.K. Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 31 U.K. Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 32 U.K. Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 33 U.K. Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 34 U.K. Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 35 Germany Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 36 Germany Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 37 Germany Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 38 Germany Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 39 Germany Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 40 France Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 41 France Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 42 France Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 43 France Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 44 France Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 45 Spain Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 46 Spain Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 47 Spain Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 48 Spain Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 49 Spain Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 50 Italy Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 51 Italy Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 52 Italy Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 53 Italy Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 54 Italy Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 55 Asia Pacific Alopecia Market, By Country, 2017 - 2028 (USD Million)
Table 56 Asia Pacific Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 57 Asia Pacific Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 58 Asia Pacific Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 59 Asia Pacific Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 60 Asia Pacific Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 61 Japan Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 62 Japan Alopecia Market, By Disease Type 2017 - 2028 (USD Million)
Table 63 Japan Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 64 Japan Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 65 Japan Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 66 China Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 67 China Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 68 China Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 69 China Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 70 China Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 71 India Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 72 India Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 73 India Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 74 India Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 75 India Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 76 South Korea Alopecia Market, By Treatment 2017 - 2028 (USD Million)
Table 77 South Korea Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 78 South Korea Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 79 South Korea Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 80 South Korea Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 81 Australia Alopecia Market, By Treatment 2017 - 2028 (USD Million)
Table 82 Australia Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 83 Australia Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 84 Australia Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 85 Australia Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 86 Latin America Alopecia Market, By Country, 2017 - 2028 (USD Million)
Table 87 Latin America Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 88 Latin America Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 89 Latin America Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 90 Latin America Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 91 Latin America Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 92 Brazil Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 93 Brazil Alopecia Market, By Disease Type 2017 - 2028 (USD Million)
Table 94 Brazil Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 95 Brazil Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 96 Brazil Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 97 Mexico Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 98 Mexico Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 99 Mexico Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 100 Mexico Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 101 Mexico Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 102 Middle East & Africa Alopecia Market, By Country, 2017 - 2028 (USD Million)
Table 103 Middle East & Africa Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 104 Middle East & Africa Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 105 Middle East & Africa Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 106 Middle East & Africa Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 107 Middle East & Africa Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 108 South Africa Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 109 South Africa Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 110 South Africa Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 111 South Africa Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 112 South Africa Alopecia Market, By End Use, 2017 - 2028 (USD Million)
Table 113 Saudi Arabia Alopecia Market, By Treatment, 2017 - 2028 (USD Million)
Table 114 Saudi Arabia Alopecia Market, By Disease Type, 2017 - 2028 (USD Million)
Table 115 Saudi Arabia Alopecia Market, By Gender, 2017 - 2028 (USD Million)
Table 116 Saudi Arabia Alopecia Market, By Sales Channel, 2017 - 2028 (USD Million)
Table 117 Saudi Arabia Alopecia Market, By End Use, 2017 - 2028 (USD Million)

List of Figures
FIG. 1 Alopecia market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2020)
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Prevalence of PCOS in 2019, by WHO regions
Fig. 13 Incidence of cancer in 2020, by WHO regions
Fig. 14 Prevalence of rheumatoid arthritis in 2019, by WHO regions
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 18 Clinical trials for alopecia areata and androgenic alopecia
Fig. 19 Alopecia market disease type outlook: Key takeaways
Fig. 20 Alopecia market: Disease type movement analysis
Fig. 21 Alopecia areata market, 2017 - 2028 (USD Million)
Fig. 22 Male alopecia areata market, 2017 - 2028 (USD Million)
Fig. 23 Female alopecia areata market, 2017 - 2028 (USD Million)
Fig. 24 Cicatricial alopecia market, 2017 - 2028 (USD Million)
Fig. 25 Male cicatricial alopecia market, 2017 - 2028 (USD Million)
Fig. 26 Female cicatricial alopecia market, 2017 - 2028 (USD Million)
Fig. 27 Traction alopecia market, 2017 - 2028 (USD Million)
Fig. 28 Male traction alopecia market, 2017 - 2028 (USD Million)
Fig. 29 Female traction alopecia market, 2017 - 2028 (USD Million)
Fig. 30 Alopecia totalis market, 2017 - 2028 (USD Million)
Fig. 31 Male alopecia totalis market, 2017 - 2028 (USD Million)
Fig. 32 Female alopecia totalis market, 2017 - 2028 (USD Million)
Fig. 33 Alopecia universalis market, 2017 - 2028 (USD Million)
Fig. 34 Male alopecia universalis market, 2017 - 2028 (USD Million)
Fig. 35 Female alopecia universalis market, 2017 - 2028 (USD Million)
Fig. 36 Androgenetic alopecia market, 2017 - 2028 (USD Million)
Fig. 37 Male androgenetic alopecia market, 2017 - 2028 (USD Million)
Fig. 38 Female androgenetic alopecia market, 2017 - 2028 (USD Million)
Fig. 39 Other alopecia market, 2017 - 2028 (USD Million)
Fig. 40 Male other alopecia market, 2017 - 2028 (USD Million)
Fig. 41 Female other alopecia market, 2017 - 2028 (USD Million)
Fig. 42 Alopecia market treatment outlook: Key takeaways
Fig. 43 Alopecia market: Treatment movement analysis
Fig. 44 Pharmaceuticals market, 2017 - 2028 (USD Million)
Fig. 45 Devices market, 2017 - 2028 (USD Million)
Fig. 46 Alopecia market end-use outlook key takeaways
Fig. 47 Alopecia market: End-use movement analysis
Fig. 48 Dermatology clinic market, 2017 - 2028 (USD Million)
Fig. 49 Homecare setting market, 2017 - 2028 (USD Million)
Fig. 50 Alopecia market sales channel outlook key takeaways
Fig. 51 Alopecia market: Sales channel movement analysis
Fig. 52 Prescription market, 2017 - 2028 (USD Million)
Fig. 53 OTC market, 2017 - 2028 (USD Million)
Fig. 54 Alopecia market gender outlook key takeaways
Fig. 55 Alopecia market: Gender movement analysis
Fig. 56 Male alopecia market, 2017 - 2028 (USD Million)
Fig. 57 Female alopecia market, 2017 - 2028 (USD Million)
Fig. 58 Regional outlook, 2020 & 2028
Fig. 59 Regional market place: Key takeaways
Fig. 60 North America
Fig. 61 North America alopecia market, 2017 - 2028 (USD Million)
Fig. 62 U.S.
Fig. 63 U.S. alopecia market, 2017 - 2028 (USD Million)
Fig. 64 Canada
Fig. 65 Canada alopecia market, 2017 - 2028 (USD Million)
Fig. 66 Europe
Fig. 67 Europe alopecia market, 2017 - 2028 (USD Million)
Fig. 68 U.K.
Fig. 69 U.K. alopecia market, 2017 - 2028 (USD Million)
Fig. 70 Germany
Fig. 71 Germany alopecia market, 2017 - 2028 (USD Million)
Fig. 72 Spain
Fig. 73 Spain alopecia market, 2017 - 2028 (USD Million)
Fig. 74 France
Fig. 75 France alopecia market, 2017 - 2028 (USD Million)
Fig. 76 Italy
Fig. 77 Italy alopecia market, 2017 - 2028 (USD Million)
Fig. 78 Asia Pacific
Fig. 79 Asia Pacific alopecia market, 2017 - 2028 (USD Million)
Fig. 80 Japan
Fig. 81 Japan alopecia market, 2017 - 2028 (USD Million)
Fig. 82 China
Fig. 83 China alopecia market, 2017 - 2028 (USD Million)
Fig. 84 India
Fig. 85 India alopecia market, 2017 - 2028 (USD Million)
Fig. 86 South Korea
Fig. 87 South Korea alopecia market, 2017 - 2028 (USD Million)
Fig. 88 Australia
Fig. 89 Australia alopecia market, 2017 - 2028 (USD Million)
Fig. 90 Latin America
Fig. 91 Latin America alopecia market, 2017 - 2028 (USD Million)
Fig. 92 Brazil
Fig. 93 Brazil alopecia market, 2017 - 2028 (USD Million)
Fig. 94 Mexico
Fig. 95 Mexico alopecia market, 2017 - 2028 (USD Million)
Fig. 96 Middle East and Africa
Fig. 97 MEA alopecia market, 2017 - 2028 (USD Million)
Fig. 98 South Africa
Fig. 99 South Africa alopecia market, 2017 - 2028 (USD Million)
Fig. 100 Saudi Arabia
Fig. 101 Saudi Arabia alopecia market, 2017 - 2028 (USD Million)
Fig. 102 Strategy mapping
Fig. 103 Heat map analysis
Fig. 104 Market differentiators

Note: Product cover images may vary from those shown
  • Cipla, Inc.
  • Sun Pharmaceuticals Industries Ltd.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc
  • Lexington Intl., LLC
  • Cirrus Hair Centers
  • Vita-Cos-Med Klett-Loch GmbH
  • Transitions Hair
  • Follica, Inc.
  • Capillus
  • Lexington Intl., LLC.
  • Freedom Laser Therapy (iRestore ID-520 helmet)
  • Curallux, LLC.
  • Apira science Inc. (iGROW Laser)
  • Revian Inc.
  • Theradome
  • lutronic
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll